Avanza Fonder AB Buys Shares of 21,951 The Cooper Companies, Inc. (NASDAQ:COO)

Avanza Fonder AB bought a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 21,951 shares of the medical device company's stock, valued at approximately $2,018,000.

A number of other hedge funds have also recently modified their holdings of COO. West Financial Advisors LLC purchased a new position in Cooper Companies during the fourth quarter worth approximately $49,000. Thurston Springer Miller Herd & Titak Inc. boosted its position in Cooper Companies by 5.2% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 5,930 shares of the medical device company's stock worth $545,000 after purchasing an additional 294 shares in the last quarter. Park Avenue Securities LLC boosted its position in Cooper Companies by 4.9% during the fourth quarter. Park Avenue Securities LLC now owns 8,087 shares of the medical device company's stock worth $743,000 after purchasing an additional 380 shares in the last quarter. Wedmont Private Capital boosted its position in Cooper Companies by 16.2% during the fourth quarter. Wedmont Private Capital now owns 4,854 shares of the medical device company's stock worth $438,000 after purchasing an additional 676 shares in the last quarter. Finally, Czech National Bank boosted its position in Cooper Companies by 6.5% during the fourth quarter. Czech National Bank now owns 43,181 shares of the medical device company's stock worth $3,970,000 after purchasing an additional 2,619 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on COO. Citigroup lowered their price target on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a research report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Morgan Stanley decreased their target price on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Friday, December 6th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Wells Fargo & Company raised their target price on Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $117.00.

Cooper Companies Trading Up 1.3 %

Shares of COO stock traded up $1.23 on Friday, hitting $93.27. The stock had a trading volume of 1,950,968 shares, compared to its average volume of 1,071,215. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market capitalization of $18.61 billion, a P/E ratio of 47.83, a P/E/G ratio of 2.29 and a beta of 0.99. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The company's 50 day moving average price is $96.54 and its 200-day moving average price is $99.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. During the same period in the previous year, the firm posted $0.87 EPS. Cooper Companies's revenue for the quarter was up 9.8% on a year-over-year basis. Analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.